Urinary Tract Infection Treatment Market Scope And Analysis

  • Report Code : TIPRE00005931
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Urinary Tract Infection Treatment Market - Analysis 2031

Buy Now

Urinary Tract Infection Treatment Market Report Urinary Tract Infection Treatment Market Size and Share Urinary Tract Infection Treatment Market Scope and Analysis

Urinary Tract Infection Treatment Market Report Scope

Report Attribute Details
Market size in 2023 US$ 10.10 Billion
Market Size by 2031 US$ 13.02 Billion
Global CAGR (2023 - 2031) 3.2%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Drug Class
  • Penicillin and Combinations
  • Quinolones
  • Cephalosporin
  • Aminoglycoside Antibiotics
  • Sulphonamides
  • Nutritional Supplements
By Indication
  • Complicated Urinary Tract Infection and Uncomplicated Urinary Tract Infection
By Distribution Channel
  • Hospital Pharmacies
  • Gynaecology and Urology Clinics
  • Retail Pharmacies and Drug Stores
  • Online Drug Stores
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Almirall SA
  • Dr Reddys Laboratories Ltd
  • Allergan
  • GlaxoSmithKline PLC
  • Shionogi Co Ltd
  • Novartis AG
  • Pfizer
  • Merck Co Inc
  • Bristol Myers Squibb Company
  • Regeneron Pharmaceuticals
    		•